Cargando…
Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Metabolic syndrome is estimated to affect more than one in five adults, and its prevalence is growing in the adult and pediatric populations. The most widely recognized metabolic risk factors are atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose. Individuals with these c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678499/ https://www.ncbi.nlm.nih.gov/pubmed/23781121 http://dx.doi.org/10.1155/2013/549627 |